Resources

Clovis Oncology, Inc. has filed for bankruptcy due to the combination of poor sales tied to its cancer drug, Rubraca, and a significant debt load.

Cover your ears, but not your eyes: if Audacy, Inc. doesn't lower its debt volume, creditors will need to look much more closely at the Philadelphia-based broadcasting giant.

WeWork Inc. continues to expand its network and carries some untapped funding sources, but has not proved that it can control its cash burn. Crowdsourced subscriber sentiment is signaling to the FRISK® score that bankruptcy could be in the cards in the coming months.

CreditRiskMonitor reported operating revenues of $4.55 million, an increase of 5%, for the three months ended Sept. 30, 2022, as compared to the third quarter of fiscal 2021.

CreditRiskMonitor reported operating revenues of $4.45 million, an increase of approximately $202 thousand or 5%, for the three months ended June 30, 2022, as compared to the second quarter of fiscal 2021.

CEOCFO Magazine recently spent some time with CreditRiskMonitor President & COO, Mike Flum, to learn about our company and the treacherous landscape both credit and procurement risk evaluators are traversing in this age of rising debt, inflation, and interest rates the world over